AI Assistant
Blog
Pricing
Log In
Sign Up
Outcomes in Patients with Poor-Risk Cytogenetics with or without
TP53
Mutations Treated with Venetoclax and Azacitidine
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
